Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 0 % of short-term debt in 2025; threshold 65 %.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
Dr. Deschuttere - Dockx Geneesherenassociatie from Antwerpen, company number BE0451494022, closed financial year 2025 with a result of € 16,759 after tax. For that financial year Dr. Deschuttere - Dockx Geneesherenassociatie recorded a gross margin of € -1,435 and equity of € 842,909. Compared with financial year 2024, the result moved from € 12,202 to € 16,759. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 28, 2026.
€ 842,909
▲ 2% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 16,759
▲ 37% vs 2024
Profit after tax over the fiscal year.
€ 0
▼ 100% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 836,703.
Debts at end 2025
€ 9
▼ 49% vs 2024
Loans from banks and other lenders, long and short.
€ 6,277
▼ 35% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 3,773 | € -2,204 | € -1,730 | € -1,435 | ▲ € 295 |
| Profit after taxes | € 14,585 | € 14,192 | € 12,202 | € 16,759 | ▲ 37% |
| Equity | € 799,756 | € 813,948 | € 826,150 | € 842,909 | ▲ 2% |
| Total debts | € 108,061 | € 93,889 | € 81,667 | € 32,091 | ▼ 61% |
| Cash | € 20 | € 40 | € 19 | € 0 | ▼ 100% |
| Retained profit | € 793,551 | € 807,743 | € 819,945 | € 836,703 | ▲ 2% |
| Bank debt | € 30 | € 0 | € 18 | € 9 | ▼ 49% |
| Balance sheet total | € 907,817 | € 907,837 | € 907,817 | € 875,000 | ▼ 4% |
Key figures of Dr. Deschuttere - Dockx Geneesherenassociatie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to Dr. Deschuttere - Dockx Geneesherenassociatie?
What happened at Dr. Deschuttere - Dockx Geneesherenassociatie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 16,759 (▲ 37% vs 2024). Source: NBB ↗
- Mark Dockx became a director. NBB
- DR. MARK DOCKX BV became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 14,585 profit in 2022 to € 16,759 profit in 2025.
Paid € 21,128 in corporate taxes since 2022.
Best year ever: 2025, with € 16,759 profit.
A new publication or filing at Dr. Deschuttere - Dockx Geneesherenassociatie? We notify you, reason included.
Follow Dr. Deschuttere - Dockx GeneesherenassociatieDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of DR. MARK DOCKX comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Dr. Deschuttere - Dockx GeneesherenassociatieBehind Dr. Deschuttere - Dockx Geneesherenassociatie are Mark Dockx and DR. MARK DOCKX BV. The shares are held by DR. MARK DOCKX (100%).
Directors
According to the 2025 annual accounts
since 2021
Director · represented by Mark Dockx
since 2018
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Kruishofstraat 140
2020 Antwerpen
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
All companies at this address →FP140
€ 244,034 gross margin · 2025
ETA Consulting
BOTTER
€ -264,983 gross margin · 2024
RAM C°
€ -1,507 gross margin · 2025
ADVANCED BIO-POLYMEER TECHNOLOGIES
€ -1,587 gross margin · 2025
+1 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0451.494.022
- VAT number
- BE 0451.494.022
- Registered office
- Kruishofstraat 140, 2020 Antwerpen
- Names & denominations
- Dr. Deschuttere - Dockx Geneesherenassociatie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 November 1993
- Peppol
- Not registered